25 research outputs found
Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' reply
Get PDFA response to the letter regarding The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury, by Mr Vincent Simmon President and CEO of Xytis Inc
Thiourea induces DNA repair synthesis in primary rat hepatocyte cultures and gene mutations in V79 Chinese hamster cells
No full textDetermination of Genotoxic Activity Using DNA Polymerase-Deficient and -Proficient E. coli
No full textIn vitro induction of alterations in peripheral blood lymphocytes by different doses of diazinon
No full textSuitability of the Ames test to characterise genotoxicity of food contact material migrates
No full text
Mechanisms of Ovotoxicity Induced by Environmental Chemicals: 4-Vinylcyclohexene Diepoxide as a Model Chemical
No full text
